По вашему запросу найдено документов: 41

Страница 1 из 5

Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study
Deal, C, Steelman, J, Vlachopapadopoulou, E, Stawerska, R, Silverman, LA;, Phillip, M, Kim, HS, Ko, CW, Malievskiy, O, Cara, JF, Roland, CL, Taylor, CT, Valluri, SR, Wajnrajch, MP, Pastrak, A, Miller, BS (2022)
the efficacy and safety of once-weekly somatrogon with once-daily somatropin in prepubertal children with GHD
Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results
Maniatis, AK;, Casella, SJ;, Nadgir, UM;, Hofman, PL;, Saenger, P;, Chertock, ED;, Aghajanova, EM;, Korpal-Szczyrska, M;, Vlachopapadopoulou, E;, Malievskiy, O;, Chaychenko, T;, Cappa, M;, Song, WJ;, Mao, M;, Mygind, PH;, Smith, AR;, Chessler, S;, Komirenko, AS;, Beckert, M;, Aimee, D Shu, Paul, S Thornton (2022)
the long-term safety and efficacy of weekly administered long-acting growth hormone lonapegsomatropin
Оценка эффективности различных методов лечения атрофической формы хронического эндометрита
Evaluation of the efficacy of different treatment modalities for chronic atrophic endometritis
Газизова, Г.Х., Ящук, А.Г., Масленников, А.В., Даутова, Л.А., Батталова, Г.Ю., Gazizova, G.Kh., Yashchuk, A.G., Maslennikov, A.V., Dautova, L.A, Battalova, G.Yu. (2022)
Evaluation of the efficacy of different treatment modalities for chronic atrophic endometritis
Первый объединенный российский опыт применения перампанела у детей и подростков с эпилепсией в повседневной клинической практике
The first combined russian experience of using perampanel in children and adolescents with epilepsy in everyday clinical practice
Rakhmanina, O.A., Volkov, I.V., Volkova, O.K., Aleksandrov, Y.A., Barkhatov, M.V., Bakhtin, I.S., Berezhnaya, G.M., Boldyreva, S.R., Bochkova, , E.N., Gorbunova, E.K., Karas, A. Yu., Morozov, D. V., Nurmukhametova, S. R., Perunova, N. Yu., Sivkova, S. N., Telegina, E. V., Tomenko, T. R., Tsotsonava, Zh. M., Рахманина, О.А., Волков, И.В., Волкова, О.К., Александров, Ю.А., Бархатов, М.В., Бахтин, И.С., Бережная, Г.М., Болдырева, С.Р., Бочкова, Е.Н., Горбунова, Е.К., Карась, А.Ю., Морозов, Д.В., Нурмухаметова, С.Р., Перунова, Н.Ю., Сивкова, С.Н., Телегина, Е.В., Томенко, Т.Р., Цоцонава, Ж.М. (2022)
efficacy and tolerability
Using a Polygenic Score to Predict the Risk of Developing Primary Osteoporosis
Yalaev, Bulat, Tyurin, Anton, Prokopenko, Inga, Karunas, Aleksandra, Khusnutdinova, Elza, Khusainova, Rita (2022)
models to predict the risk of low fractures in women from the Volga-Ural region of Russia with efficacy
Safety, Efficacy and Long-Term Outcomes of Patients Treated with the Occlutech Paravalvular Leak Device for Significant Paravalvular Regurgitation
Onorato, EM, Alamanni, F, Muratori, M, Smolka, G, Wojakowski, W, Pysz, P, Zorinas, A, Zakarkaite, D, Eltchaninoff, H, Litzer, PY, Godart, F, Calvert, P, Christou, C, Mussayev, A, Missiroli, B, Buzaev, I, Curello, S, Tesorio, T, Bartorelli, AL (2022)
Safety, Efficacy and Long-Term Outcomes of Patients Treated with the Occlutech Paravalvular Leak
Герминальные мутации как возможные биомаркеры эффективности терапии ингибиторами контрольных точек иммунитета у пациентов с почечно-клеточной карциномой (мини-обзор)
Germline mutations as possible biomarkers of immune checkpoint inhibitor therapy efficacy in patients with renal cell carcinoma (mini review)
Гилязова, И.Р., Асадуллина, Д.Д., Иванова, Е.А., Рахимов, Р.Р., Измайлов, А.А., Бермишева, М.А., Гилязова, Г.Р., Шарифгалеев, И.А., Урманцев, М.Ф., Попова, Е.В., Сафиханов, Р.Я., Павлов, В.Н., Хуснутдинова, Э.К., Gilyazova, I.R., Asadullina, D.D., Ivanova, E.A., Rakhimov, R.R., Izmailov, A.A., Bermisheva, M.A., Gilyazova, G.R., Sharifgaleev, I.A., Urmantsev, M.F., Popova, E.V., Safikhanov, R.Ya., Pavlov, V.N., Khusnutdinova, E.K. (2022)
Germline mutations as possible biomarkers of immune checkpoint inhibitor therapy efficacy
ЭФФЕКТИВНОСТЬ ИНГИБИТОРА ТИРОЗИНКИНАЗ 1-ГО ПОКОЛЕНИЯ (СУНИТИНИБ) В ТЕРАПИИ МЕТАСТАТИЧЕСКОГО ПОЧЕЧНО-КЛЕТОЧНОГО РАКА В АЛЬТЕРНАТИВНЫХ РЕЖИМАХ ДОЗИРОВАНИЯ
EFFICACY OF THE 1ST GENERATION TYROSINE KINASE INHIBITOR SUNITINIB IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN ALTERNATIVE DOSING REGIMENS
МЕНЬШИКОВ, К. В., СУЛТАНБАЕВ, А. В., МУСИН, Ш. И., ИЗМАЙЛОВ, А. A., ЧАЛОВ, В. С., МЕНЬШИКОВА, И. А., СУЛТАНБАЕВА, Н. И., ПОПОВА, Е. В., ЛИПАТОВ, Д. О., MENSHIKOV, K. V., SULTANBAEV, A. V., MUSIN, SH. I., IZMAILOV, A. A., CHALOV, V. S., MENSHIKOVA, I. A., SULTANBAEVA, N. I., POPOVA, E. V., LIPATOV, D. O. (2022)
EFFICACY OF THE 1ST GENERATION TYROSINE KINASE INHIBITOR SUNITINIB IN THE TREATMENT OF METASTATIC
Therapeutic effect of natural polyphenols against glioblastoma
Beylerli, Ozal, Beilerli, Aferin, Shumadalova, Alina, Wang, Xiaoxiong, Yang, Mingchun, Sun, Hanran, Teng, Lei (2022)
. Although these beneficial effects are promising, the efficacy of natural polyphenolic compounds in GBM
DIAGNOSIS AND TREATMENT OF MILLER CLASS I GINGIVAL RECESSION USING FREE CONNECTIVE TISSUE AUTOGRAFT FROM THE HARD PALATE. CLINICAL OBSERVATION
Farkhshatova, R, Gerasimova, L, Usmanova, I, Daurova, F, Golub, A, Aletdinova, S (2022)
treatment. The average percentage efficacy of recession coverage in the study group was - 84%. Pain

Страница 1 из 5

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год